Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Changes in Stockholders' Equity

v3.21.1
Condensed Consolidated Statement of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Series A PerpetualPreferred Stock [Member]
Common Stock [Member]
Shares Issuable [Member]
Treasury Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Non-Controlling Interests [Member]
Total
Balance at Dec. 31, 2019 $ 1 $ 74 $ 500   $ 461,874 $ (436,234) $ 46,317 $ 72,532
Balance (in shares) at Dec. 31, 2019 1,341,167 74,027,425            
Stock-based compensation expense         3,400     3,400
Issuance of common stock related to equity plans   $ 2     (2)      
Issuance of common stock related to equity plans (in shares)   1,952,407            
Preferred A dividends declared and paid         (1,207)     (1,207)
Partner company's at-the-market offering, net         4,910     4,910
Issuance of common stock for at-the-market offering, net   $ 3     5,877     5,880
Issuance of common stock for at-the-market offering, net (in shares)   2,341,000            
Repurchase of Series A preferred stock, net       $ (70) (2)     (72)
Repurchase of Series A preferred stock (in shares) (5,000)              
Issuance of Series A preferred stock for cash, net $ 1       13,066     13,067
Issuance of Series A preferred stock for cash, net (in shares) 718,750              
Issuance of common stock under partner company's ESPP         169     169
Partner company's exercise of warrants for cash         13     13
Common shares issued for 2017 Subordinated Note Financing interest expense     (500)   500      
Common shares issued for 2017 Subordinated Note Financing interest expense (in shares)   251,337            
Common shares issuable for 2017 Subordinated Note Financing interest expense     506         506
Non-controlling interest in partner companies         (3,438)   3,438  
Net loss attributable to non-controlling interest             (11,698) (11,698)
Net loss attributable to common stockholders           (12,370)   (12,370)
Common shares issuable for 2019 Notes interest expense     155         155
Balance at Mar. 31, 2020 $ 2 $ 79 661 (70) 485,160 (448,604) $ 38,057 75,285
Balance (in shares) at Mar. 31, 2020 2,054,917 78,572,169            
Balance at Dec. 31, 2020 $ 3 $ 95 583,000 (482,760) 96,661 196,999   196,999
Balance (in shares) at Dec. 31, 2020 3,427,138 94,877,492            
Stock-based compensation expense     3,773     3,773    
Issuance of common stock related to equity plans   $ 2 (2)          
Issuance of common stock related to equity plans (in shares)   2,385,562            
Preferred A dividends declared and paid     (2,007)     (2,007)    
Partner company's at-the-market offering, net     71,422     71,422    
Partner company's exercise of options for cash     7     7    
Issuance of common stock under ESPP     158     158    
Partner company's dividends declared and paid     $ (187)     (187)    
Issuance of partner company's common shares for research and development expenses           126    
Issuance of common stock for research and development expenses (in shares)     126,000          
Non-controlling interest in partner companies     $ (58,906)   58,906      
Net loss attributable to non-controlling interest         (17,244) (17,244)    
Net loss attributable to common stockholders       (8,822)   (8,822)   (8,822)
Balance at Mar. 31, 2021 $ 3 $ 97 $ 597,384 $ (491,582) $ 138,323 $ 244,225   $ 244,225
Balance (in shares) at Mar. 31, 2021 3,427,138 97,263,054